Form 8-K - Current report:
SEC Accession No. 0001193125-24-230144
Filing Date
2024-10-01
Accepted
2024-10-01 16:05:35
Documents
73
Period of Report
2024-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d873729d8k.htm   iXBRL 8-K 57938
2 EX-10.1 d873729dex101.htm EX-10.1 70374
3 EX-10.2 d873729dex102.htm EX-10.2 266956
4 EX-10.3 d873729dex103.htm EX-10.3 89827
5 EX-10.4 d873729dex104.htm EX-10.4 55522
6 EX-99.1 d873729dex991.htm EX-99.1 13270
7 EX-99.2 d873729dex992.htm EX-99.2 243708
11 GRAPHIC g873729dsp100.jpg GRAPHIC 121145
12 GRAPHIC g873729dsp101.jpg GRAPHIC 89211
13 GRAPHIC g873729dsp102.jpg GRAPHIC 129336
14 GRAPHIC g873729dsp103.jpg GRAPHIC 91283
15 GRAPHIC g873729dsp104.jpg GRAPHIC 103480
16 GRAPHIC g873729dsp105.jpg GRAPHIC 113751
17 GRAPHIC g873729dsp106.jpg GRAPHIC 113073
18 GRAPHIC g873729dsp107.jpg GRAPHIC 55299
19 GRAPHIC g873729dsp108.jpg GRAPHIC 67630
20 GRAPHIC g873729dsp109.jpg GRAPHIC 68936
21 GRAPHIC g873729dsp110.jpg GRAPHIC 101000
22 GRAPHIC g873729dsp111.jpg GRAPHIC 96523
23 GRAPHIC g873729dsp112.jpg GRAPHIC 21052
24 GRAPHIC g873729dsp59.jpg GRAPHIC 27218
25 GRAPHIC g873729dsp60.jpg GRAPHIC 102751
26 GRAPHIC g873729dsp61.jpg GRAPHIC 134365
27 GRAPHIC g873729dsp62.jpg GRAPHIC 115759
28 GRAPHIC g873729dsp63.jpg GRAPHIC 126442
29 GRAPHIC g873729dsp64.jpg GRAPHIC 117494
30 GRAPHIC g873729dsp65.jpg GRAPHIC 64431
31 GRAPHIC g873729dsp66.jpg GRAPHIC 123270
32 GRAPHIC g873729dsp67.jpg GRAPHIC 113216
33 GRAPHIC g873729dsp68.jpg GRAPHIC 116998
34 GRAPHIC g873729dsp69.jpg GRAPHIC 107610
35 GRAPHIC g873729dsp70.jpg GRAPHIC 66652
36 GRAPHIC g873729dsp71.jpg GRAPHIC 122163
37 GRAPHIC g873729dsp72.jpg GRAPHIC 65902
38 GRAPHIC g873729dsp73.jpg GRAPHIC 123224
39 GRAPHIC g873729dsp74.jpg GRAPHIC 78129
40 GRAPHIC g873729dsp75.jpg GRAPHIC 117301
41 GRAPHIC g873729dsp76.jpg GRAPHIC 118067
42 GRAPHIC g873729dsp77.jpg GRAPHIC 122410
43 GRAPHIC g873729dsp78.jpg GRAPHIC 117223
44 GRAPHIC g873729dsp79.jpg GRAPHIC 97887
45 GRAPHIC g873729dsp80.jpg GRAPHIC 129146
46 GRAPHIC g873729dsp81.jpg GRAPHIC 120827
47 GRAPHIC g873729dsp82.jpg GRAPHIC 116327
48 GRAPHIC g873729dsp83.jpg GRAPHIC 108783
49 GRAPHIC g873729dsp84.jpg GRAPHIC 102904
50 GRAPHIC g873729dsp85.jpg GRAPHIC 107093
51 GRAPHIC g873729dsp86.jpg GRAPHIC 105458
52 GRAPHIC g873729dsp87.jpg GRAPHIC 144279
53 GRAPHIC g873729dsp88.jpg GRAPHIC 138425
54 GRAPHIC g873729dsp89.jpg GRAPHIC 116559
55 GRAPHIC g873729dsp90.jpg GRAPHIC 103769
56 GRAPHIC g873729dsp91.jpg GRAPHIC 115852
57 GRAPHIC g873729dsp92.jpg GRAPHIC 102299
58 GRAPHIC g873729dsp93.jpg GRAPHIC 62471
59 GRAPHIC g873729dsp94.jpg GRAPHIC 98487
60 GRAPHIC g873729dsp95.jpg GRAPHIC 113119
61 GRAPHIC g873729dsp96.jpg GRAPHIC 110316
62 GRAPHIC g873729dsp97.jpg GRAPHIC 117764
63 GRAPHIC g873729dsp98.jpg GRAPHIC 115161
64 GRAPHIC g873729dsp99.jpg GRAPHIC 134956
  Complete submission text file 0001193125-24-230144.txt   8661041

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20240930.xsd EX-101.SCH 2868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20240930_lab.xml EX-101.LAB 17235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20240930_pre.xml EX-101.PRE 10824
75 EXTRACTED XBRL INSTANCE DOCUMENT d873729d8k_htm.xml XML 3507
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 241343243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)